Haleon (HLN) Shares Outstanding (Weighted Average) (2021 - 2025)

Haleon (HLN) recorded quarterly Shares Outstanding (Weighted Average) of $119.7 million in Q4 2025, up 2.5% on a QoQ basis from $116.8 million in Q4 2024, and up 2.5% year-over-year from $116.8 million in Q4 2024.

Haleon (HLN) Shares Outstanding (Weighted Average) (2021 - 2025) Analysis & Trends

Haleon has disclosed Shares Outstanding (Weighted Average) across 5 years of filings, most recently posting $119.7 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.5% year-over-year to $119.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $119.7 million (up 2.5% YoY) and the FY2025 annual result came in at $118.7 million, up 2.01% from the prior year.
  • Shares Outstanding (Weighted Average) rose to $119.7 million in Q4 2025, from $116.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $115.1 billion in Q2 2023 and troughed at $116.8 million in Q4 2024.
  • A 5-year average of $17.3 billion and a median of $8.4 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) jumped 9041.91% — and 2024, when it plunged 98.98%.
  • Tracing HLN's Shares Outstanding (Weighted Average) over 5 years: stood at $12.4 billion in 2021, then retreated by 12.99% to $10.8 billion in 2022, then rose by 5.79% to $11.5 billion in 2023, then tumbled by 98.98% to $116.8 million in 2024, then advanced by 2.5% to $119.7 million in 2025.
  • Business Quant data shows HLN's Shares Outstanding (Weighted Average) at $119.7 million in Q4 2025, $116.8 million in Q4 2024, and $10.0 billion in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Haleon 1.09 Bn -773.69 Mn - 119.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 119.71 Mn
Dec 31, 2024 116.80 Mn
Jun 30, 2024 9.97 Bn
Dec 31, 2023 11.46 Bn
Jun 30, 2023 115.13 Bn
May 3, 2023 5.14 Bn
Dec 31, 2022 10.83 Bn
Sep 20, 2022 6.90 Bn
Jun 30, 2022 1.26 Bn
Dec 31, 2021 12.45 Bn